Mohammed Belmekki
Research Subjects
Mohammed Belmekki has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Kawtar Megdiche
Cheikh Zaïd Foundation Medical Simulation Center, Morocco
1 shared publication - Nabil Ngote
Université Internationale Abulcasis des Sciences de la Santé de Rabat
1 shared publication - Nabila Zrira
ADOS Team, LISTD Laboratory, National Superior School of Mines, Rabat, Morocco
1 shared publication - Nissrine Souissi
MINES-RABAT School, Rabat, Morocco
1 shared publication - Safia Benamar
Cheikh Zaïd Ophthalmic Center, Cheikh Zaïd International University Hospital, Rabat 10000, Morocco
1 shared publication - Zineb Farahat
International Abulcasis University of Health Sciences (UIASS)
1 shared publication
Latest Publications
- Open Access
- 10 May 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (10) , 1694
Application of Deep Learning Methods in a Moroccan Ophthalmic Center: Analysis and Discussion
Diabetic retinopathy (DR) remains one of the world’s frequent eye illnesses, leading to vision loss among working-aged individuals. Hemorrhages and exudates are examples of signs of DR. However, artificial intelligence (AI), particularly deep learning (DL), is poised to impact nearly every aspect of human life and gradually transform medical practice. Insight into the condition of the retina is becoming more accessible thanks to major advancements in diagnostic technology. AI approaches can be used to assess lots of morphological datasets derived from digital images in a rapid and noninvasive manner. Computer-aided diagnosis tools for automatic detection of DR early-stage signs will ease the pressure on clinicians. In this work, we apply two methods to the color fundus images taken on-site at the Cheikh Zaïd Foundation’s Ophthalmic Center in Rabat to detect both exudates and hemorrhages. First, we apply the U-Net method to segment exudates and hemorrhages into red and green colors, respectively. Second, the You Look Only Once Version 5 (YOLOv5) method identifies the presence of hemorrhages and exudates in an image and predicts a probability for each bounding box. The segmentation proposed method obtained a specificity of 85%, a sensitivity of 85%, and a Dice score of 85%. The detection software successfully detected 100% of diabetic retinopathy signs, the expert doctor detected 99% of DR signs, and the resident doctor detected 84%.
- 10 May 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (10) , 1694
Open AccessApplication of Deep Learning Methods in a Moroccan Ophthalmic Center: Analysis and Discussion
Diabetic retinopathy (DR) remains one of the world’s frequent eye illnesses, leading to vision loss among working-aged individuals. Hemorrhages and exudates are examples of signs of DR. However, artificial intelligence (AI), particularly deep learning (DL), is poised to impact nearly every aspect of human life and gradually transform medical practice. Insight into the condition of the retina is becoming more accessible thanks to major advancements in diagnostic technology. AI approaches can be used to assess lots of morphological datasets derived from digital images in a rapid and noninvasive manner. Computer-aided diagnosis tools for automatic detection of DR early-stage signs will ease the pressure on clinicians. In this work, we apply two methods to the color fundus images taken on-site at the Cheikh Zaïd Foundation’s Ophthalmic Center in Rabat to detect both exudates and hemorrhages. First, we apply the U-Net method to segment exudates and hemorrhages into red and green colors, respectively. Second, the You Look Only Once Version 5 (YOLOv5) method identifies the presence of hemorrhages and exudates in an image and predicts a probability for each bounding box. The segmentation proposed method obtained a specificity of 85%, a sensitivity of 85%, and a Dice score of 85%. The detection software successfully detected 100% of diabetic retinopathy signs, the expert doctor detected 99% of DR signs, and the resident doctor detected 84%.